| Value | ₹95.00 Cr |
|---|
NSE filing, NSE: SENORES. Summary written from the filing by ALFA Finder's alert engine.
Senores Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,215.00
- Market cap
- ₹5,596 Cr
- Revenue (annual)
- ₹632.6 Cr
- Net profit (annual)
- ₹115.4 Cr
- P/E (TTM)
- 41.9×Sector 46.1×
- Promoter holding
- 45.82%+0.00% QoQ
- FII holding
- 6.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Senores Pharmaceuticals Ltd
All →Senores Pharmaceuticals Earnings Call Transcript: Key Takeaways
Senores delivered record quarterly revenue and EBITDA, driven by US portfolio expansion and regulated market growth.
- Call
- Guides 40% growth
Senores Pharmaceuticals Capacity Expansion: ₹20 Cr Investment
Senores Pharmaceuticals' subsidiary Apnar Pharma Private Limited plans a 0.7 Bn unit capacity addition by March 2027. The investment is Rs.20.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹20.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.7 Bn units
Senores Pharmaceuticals Capacity Expansion: ₹18 Cr Investment
Senores Pharmaceuticals plans to add 0.8 Bn units of capacity to its existing 1.2 Bn unit plant by March 2027. The investment is Rs.18.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹18.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.8 Bn units
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Senores Pharmaceuticals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹192.3 Cr (+24.9%), EBITDA ₹57.7 Cr (+38.3%, 30.0% margin), PAT ₹36.6 Cr. H1 revenue +30%, EBITDA +58.2%.
Senores Pharmaceuticals Results Update
Senores reported Q2 FY27 revenue of ₹192 cr and EBITDA of ₹58 cr, both record highs. PAT grew 22% Y-o-Y to ₹37 cr with positive FY27 outlook.
Other other announcement announcements
All →Persistent Systems Other Announcement
Persistent Systems filed its shareholding pattern for 26 October 2026, reflecting the increase in paid-up capital from its QIP allotment. The filing shows the post-allotment shareholding split.
Sunsky Logistics Other Announcement
Sunsky Logistics reported IPO proceeds of Rs 1,683.27 lakh utilised out of Rs 1,683.60 lakh raised for the half year ended September 30, 2026. The filing reports no deviation or variation, and the statutory auditor has certified the utilisation.
E to E Transportation Infrastructure Other Announcement
E To E Transportation Infrastructure filed a governance non-applicability notice for Q2 FY27 as an SME-listed company. It also reported nil investor complaints for the quarter.
Bank of India Other Announcement
Bank of India revised its MCLR effective November 1, 2026, lifting the 3-month rate to 8.45%. Fixed Rate Spread rates were also changed.
MRC Agrotech Other Announcement
Wordexx Ventures Pvt Ltd sold 5,84,823 MRC Agrotech shares in a market sale, worth about Rs.1.97 Crore. Its holding fell from 10.62% to 8.75%.
- Value
- ₹1.97 Cr
Infonative Solutions Other Announcement
Infonative Solutions reported nil investor complaints for the quarter ended 30 September 2026, as required under Regulation 13(3). This is compliance with no financial or business impact.